Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.87 +0.07 (+1.84%)
At close: Oct 21, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Asset Utilization Ratio (2023)

Updated

Unicycive Therapeutics' Asset Utilization Ratio was 0.04 in Q4 2023, up 25.8% from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Asset Utilization Ratio (2023) Analysis & Trends

For FY2023, Asset Utilization Ratio at Unicycive Therapeutics came in at 0.08, down 10.0% from FY2022.

  • In earlier years, Asset Utilization Ratio was 0.09 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Unicycive Therapeutics 104.17 Mn -95.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 0.04
Sep 30, 2023 0.03
Jun 30, 2023 0.06
API Access

Unicycive Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=UNCY&period=max&api_key=YOUR_API_KEY